BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37213158)

  • 21. MicroRNA-625-3p promotes the proliferation, migration and invasion of thyroid cancer cells by up-regulating astrocyte elevated gene 1.
    Fang L; Kong D; Xu W
    Biomed Pharmacother; 2018 Jun; 102():203-211. PubMed ID: 29558717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis.
    Han JY; Guo S; Wei N; Xue R; Li W; Dong G; Li J; Tian X; Chen C; Qiu S; Wang T; Xiao Q; Liu C; Xu J; Chen KS
    Biomed Res Int; 2020; 2020():9875636. PubMed ID: 32685551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-150-5p affects cell proliferation, apoptosis, and EMT by regulation of the BRAF
    Yan R; Yang T; Zhai H; Zhou Z; Gao L; Li Y
    J Cell Biochem; 2018 Nov; 119(11):8763-8772. PubMed ID: 30126001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1.
    Bai X; Xu Y; Liu Y
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
    J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
    Zheng H; Fu Q; Ma K; Shi S; Fu Y
    Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK/ERK/PI3K signaling.
    Jiang Y; Liu Y; Zhang Y; Ouyang J; Feng Y; Li S; Wang J; Zhang C; Tan L; Zhong J; Zou L
    Cell Signal; 2023 Sep; 109():110792. PubMed ID: 37406787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
    Peng Y; Fang X; Yao H; Zhang Y; Shi J
    Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
    [No Abstract]   [Full Text] [Related]  

  • 29. MicroRNA-203a-3p may prevent the development of thyroid papillary carcinoma via repressing MAP3K1 and activating autophagy.
    Dai L; Zhang W; Wu X; Zhou S
    J Clin Lab Anal; 2022 Jun; 36(6):e24470. PubMed ID: 35524422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-486 inhibits cell proliferation, invasion and migration via down-regulating the TENM1 expressions and affecting ERK and Akt signaling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma.
    Sun YH; Liu ZF; Yang BB; Yu B
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8429-8439. PubMed ID: 31646573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
    Wang Y; Liu BG; Zhou CX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4.
    Liu Y; Zhang H; Wang H; Du J; Dong P; Liu M; Lin Y
    Bioengineered; 2021 Dec; 12(1):496-506. PubMed ID: 33522355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
    Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-326 inhibits the progression of papillary thyroid carcinoma by targeting MAPK1 and ERBB4.
    Nie FR; Li QX; Wei HF; Ma Y
    Neoplasma; 2020 May; 67(3):604-613. PubMed ID: 32266816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-222-3p promotes the proliferation, migration and invasion of papillary thyroid carcinoma cells through targeting SLC4A4.
    Zhang C; Chang Q; Hu Y; Chang W; Guo X; Fu L; Tang G; Chen C
    Histol Histopathol; 2021 Nov; 36(11):1199-1207. PubMed ID: 34708859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
    Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
    Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
    Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
    Bi CL; Zhang YQ; Li B; Guo M; Fu YL
    J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway.
    Chen Y; Hao SA; Jiang Y; Gao B; Tian WG; Zhang S; Guo LJ; Wang LL; Luo DL
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7989-7999. PubMed ID: 31599424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway.
    Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
    J Cell Physiol; 2020 Mar; 235(3):2492-2505. PubMed ID: 31565805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.